Rockbridge Investment Management, Lcc Biogen Inc. Transaction History

Rockbridge Investment Management, Lcc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $1,112 - $1,339	-5 Closed	0 $0
Q3 2022 May 28, 2024	SELL	$194.69 - $268.46 $973 - $1,342	-5 Closed	0 $0
Q1 2022 May 28, 2024	BUY	$193.77 - $244.14 $968 - $1,220	5 New	5 $1,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $4,244 - $5,535	-15 Reduced 75.0%	5 $1,000
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $4,921 - $7,879	-19 Reduced 48.72%	20 $7,000
Q1 2021 May 20, 2021	SELL	$242.95 - $284.63 $1,457 - $1,707	-6 Reduced 13.33%	39 $11,000
Q2 2020 Aug 20, 2020	BUY	$258.66 - $342.55 $11,639 - $15,414	45 New	45 $12,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.